Home Newsfeeds Cowen & Co. Maintains Outperform on Wolfspeed, Raises Price Target to $125

Cowen & Co. Maintains Outperform on Wolfspeed, Raises Price Target to $125

Cowen & Co. analyst Matthew Ramsay maintains Wolfspeed (NYSE:WOLF) with a Outperform and raises the price target from $100 to $125.

byBenzinga Newsdesk

August 18, 2022

1 minute read

Cowen & Co. analyst Matthew Ramsay maintains Wolfspeed (NYSE:WOLF) with a Outperform and raises the price target from $100 to $125.

Movers
News

What’s Going On With ChargePoint Stock Thursday?

By Adam Eckert

January 11, 10:10 AM

After the market close on Wednesday, ChargePoint announced a reorganization that includes a 12% workforce reduction.

CHPT

Analyst Ratings

Expert Ratings for CVS Health

By Benzinga Insights

June 20, 1:00 PM

CVS Health (NYSE:CVS) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

CVS

AstraZeneca To Acquire US Respiratory Vaccine Player Icosavax For Over $800M

By Vandana Singh

December 12, 6:55 AM

AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Icosavax Inc (NASDAQ: ICVX) at $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable up

AZN

Clipper Realty Q2 EPS $0.12 Up From $0.10 YoY, Sales $31.90M Beat $31.31M Estimate

By Benzinga Newsdesk

August 9, 4:08 PM

Clipper Realty (NYSE:CLPR) reported quarterly earnings of $0.12 per share. This is a 20 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $31.90

CLPR

Cowen & Co. Maintains Outperform on Wolfspeed, Raises Price Target to $125

Related Posts

What’s Going On With ChargePoint Stock Thursday?

Expert Ratings for CVS Health

AstraZeneca To Acquire US Respiratory Vaccine Player Icosavax For Over $800M

Clipper Realty Q2 EPS $0.12 Up From $0.10 YoY, Sales $31.90M Beat $31.31M Estimate